# Levetiracetam Treatment of L-dopa Induced Dyskinesias

> **NCT00076674** · PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 40 (—)

## Conditions studied

- Dyskinesias
- Parkinson Disease

## Interventions

- **DRUG:** Intravenous Levodopa

## Key facts

- **NCT ID:** NCT00076674
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 40 (—)
- **Last updated:** 2016-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00076674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00076674, "Levetiracetam Treatment of L-dopa Induced Dyskinesias". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00076674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*